The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Systems Immunology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1439082
This article is part of the Research Topic Single Cell Technologies for the Interrogation of Immunological Disease Mechanisms View all 9 articles
Upregulation of interferon-γ response genes in monocytes and T cells identified by single-cell transcriptomics in patients with anticitrullinated peptide antibody-positive early rheumatoid arthritis
Provisionally accepted- 1 Center for Integrative Rheumatoid Transcriptomics and Dynamics, Catholic University of Korea, Seoul, Seoul, Republic of Korea
- 2 Surgery and Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California, United States
- 3 Division of Rheumatology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang-si, Republic of Korea
- 4 Catholic iPSC Research Center, Catholic University of Korea, Seoul, Seoul, Republic of Korea
- 5 YiPSCELL Inc, Seoul, Republic of Korea
- 6 Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, Seoul, Republic of Korea
- 7 Emeritus Professor of The Catholic University of Korea and Ho-Youn Kim’s Clinic for Arthritis Rheumatism, Seoul,, Republic of Korea
Introduction: Our aim was to investigate the insufficiently understood differences in the immune system between anti-citrullinated peptide antibody (ACPA)-positive (ACPA+) and ACPA-negative (ACPA-) early rheumatoid arthritis (eRA) patients. Methods: We performed multiple cytokine assays using sera from drug-naïve ACPA+ and ACPA- eRA patients. Additionally, we conducted single-cell RNA sequencing of CD45+ cells from peripheral blood samples to analyze and compare the distribution and functional characteristics of the cell subsets based on the ACPA status. Results: Serum concentrations of interferon-γ (IFN-γ) and interleukin (IL)-12 were higher in ACPA+ eRA than in ACPA- eRA. Single-cell transcriptome analysis of 37,318 cells identified 17 distinct cell types and revealed the expansion of IL1B+ proinflammatory monocytes, IL7R+ T cells, and CD8+ CCL4+ T cells in ACPA+ eRA. Furthermore, we observed an enrichment of IFN-γ response genes in nearly all monocytes and T cells of ACPA+ eRA subsets. Heightened interactions between IFN-γ and IFN-γ receptors were observed in ACPA+ eRA, particularly between monocytes and T cells. We examined IFITM2 and IFITM3 as potential key markers in ACPA+ eRA given their pronounced upregulation and association with the IFN response. Specifically, the expression of these genes was elevated in IL1B+ proinflammatory monocytes (likely M1 monocytes), correlating with serum IFN-γ levels. Discussion: Compared to ACPA- eRA, ACPA+ eRA showed higher serum IFN-γ and IL-12 levels, upregulated IFN-γ response genes, and enhanced IFN-γ-driven monocyte-T cell interactions. These distinct immune features of the peripheral circulation in ACPA+ eRA suggest a role for type 1 helper T cell-related immunity in its pathogenesis.
Keywords: Single-cell transcriptomics, peripheral blood mononuclear cells, Anti-citrullinated peptide antibody, Rheumatoid arthritis, rheumatoid arthritis pathogenesis, Th1 immunity, interferon signature, IFITM2/3
Received: 27 May 2024; Accepted: 16 Dec 2024.
Copyright: © 2024 Hong, You, Kim, Lee, Lee, Baek, Ju, Kim and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wan-Uk Kim, Center for Integrative Rheumatoid Transcriptomics and Dynamics, Catholic University of Korea, Seoul, 110-530, Seoul, Republic of Korea
Ho-Youn Kim, Emeritus Professor of The Catholic University of Korea and Ho-Youn Kim’s Clinic for Arthritis Rheumatism, Seoul,, Republic of Korea
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.